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Objective: The purpose of this systematic review is to summarize the best available evidence on interventions
that could be implemented in the college environment to increase HPV vaccination uptake in college students
who were not previously vaccinated.
Methods: Pubmed, CINAHL, PsycINFO, Cochrane, and EBSCO were searched in December 2017 to identify all
literature meeting the following criteria: human subjects, English language, HPV, HPV vaccination, and college.
PRISMA recommendations were followed. We focused only on manuscripts that reported vaccine uptake, excluding studies that only reported vaccine intentions. We identiﬁed 2989 articles; 101 relevant after screening;
nine eligible for ﬁnal qualitative review.
Results: Vaccine uptake rates ranged from 5% to 53%. Theory-based variables (e.g., perceived susceptibility and
self-eﬃcacy) were associated with vaccine uptake in most studies. A study exposing participants to a narrative
video about HPV vaccination led by a combination of peers and medical experts produced the greatest diﬀerence
in HPV vaccination initiation compared to a control group (21.8% vs 11.8%) of all the studies reviewed.
Conclusions: Few interventions resulted in substantial HPV vaccine uptake. A combination of peer and provider
encouragement may be the most eﬀective method to increase vaccine uptake in this population.

1. Introduction
Human papillomavirus (HPV) is the most common sexually transmitted infection in the United States, with an estimated 14 million individuals newly infected annually (Satterwhite et al., 2013). HPV is
responsible for > 38,000 cases of cancer in the United States each year,
including 91% of all anal and cervical cancers, 75% of vaginal and
vulvar cancers, and 63% of penile cancers (Viens, 2016). Each year >
4000 women die from cervical cancer alone in the U.S. (Singh, 2017).
An eﬀective HPV vaccination that can prevent most of the cancers from
ever developing has been available since 2006. It has been recommended as a routine vaccination at 11 or 12 years of age for females
since 2006 and for males since 2011 (Meites, 2016). Catch-up vaccination is recommended for females through age 26 and through age 21
for males. Vaccination is recommended through age 26 for men who

have sex with men and transgender persons. Three doses of HPV vaccine are recommended for males and females 9 to 26 with primary or
secondary immunocompromising conditions (Meites, 2016).
Despite these recommendations HPV vaccination uptake remains
suboptimal. The 2016 National Immunization Survey report for adolescents estimates that 49.5% of females and 37.5% of males were upto-date on HPV vaccination (Walker, 2017). A variety of reasons for
poor uptake have been identiﬁed including cost, the need for multiple
visits to complete the series, and concerns that getting vaccinated will
encourage teens to engage in risky sexual behavior (Forster et al., 2010;
Holman et al., 2014; Quinn et al., 2014). Data indicate that young
women aged 18–26 are less likely to initiate and complete the HPV
vaccination series compared to those aged 13–17 (Tan et al., 2011).
This is unfortunate as early adulthood is a prime opportunity for cancer
prevention using the vaccine. While many may not perceive themselves
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Records identified through database
searching
(n = 2,989 )

Records after duplicates removed
(n = 1,441 )

Records screened based on
title/abstract (n =1,441 )

Records excluded
(n =1,340 )

Full-text articles assessed
for eligibility
(n = 101 )

Full-text articles excluded (n=92)
Exclusion reasons:
Not an intervention = 50
Not college students = 12
Repeat data (dissertation that was
later published) = 5

Studies included in
qualitative synthesis
(n = 9 )

Not available in English = 2
Repeat publication = 1
Only reported intention to
vaccinate = 22

Fig. 1. Flow diagram of article selection.

increase HPV vaccination uptake in young adults and to summarize,
evaluate, and provide recommendations based on the results.

to be at risk, average lifetime probability of acquiring HPV is 84.6% for
females and 91.3% for males with at least one sexual partner of the
opposite sex (Chesson et al., 2014). There is an urgent unmet need to
identify eﬀective strategies to encourage catch-up vaccination for those
who reach young adulthood unvaccinated.
College campuses represent an opportunity to ﬁll this need for a
signiﬁcant portion of the young adult population. College students are
able to make their own health care decisions, are usually required to
have health insurance, and have regular access to campus health centers (McBride et al., 2010; Turner and Hurley, 2002; United States
Government Accountability Oﬃce, 2008). The American College
Health Association included HPV vaccination as an objective in Healthy
Campus 2020 (American College Health Association, 2012). For an
institution to invest in an intervention to improve the long-term health
of students, there must be good evidence that it impacts the targeted
health behavior. Previous research has demonstrated that the correlation between HPV vaccination intention and behavior is not as high as
would be expected (Juraskova et al., 2012). For this reason, focusing on
actual HPV vaccination uptake as compared to intention to get vaccinated is important to guide program planning. The purpose of this
systematic review is to provide the best available evidence on interventions that could be implemented in the college environment to

2. Methods
The Preferred Reporting Items for Systematic Reviews and MetaAnalyses (PRISMA) was utilized to guide the systematic review of the
literature (Moher et al., 2009). PRISMA oﬀers structured guidance for
reviews and provided the basis for the review protocol used in the
current study. Potential articles were identiﬁed via searches of Cochrane, PubMed, CINAHL, PsycINFO, and EBSCO databases. Each
search was limited to articles in the English language and those that
utilized human subjects. In order to identify all available literature, no
date limits were applied. The databases were searched in December
2017 using the terms “HPV” AND “college” AND “vaccine” and repeated by substituting “vaccination” as the last search term. The Cochrane database was search with the terms “HPV” AND “vaccine” as
well as “HPV” AND “vaccination.” A total of 1441 non-duplicate articles
were identiﬁed through these searches.
All identiﬁed articles were screened for full-text review. Inclusions
for full-text review included (1) focused on college students, (2) focused
on HPV vaccination, and (3) included some intervention or program to
2
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Venkatesan, 2011). Three studies went at least as long as a semester,
with one assessing uptake at six months after the intervention, (Patel
et al., 2012) one at seven months, (Richman et al., 2016) and one at ten
months. Five of the studies utilized chi-square analyses to compare HPV
vaccine uptake rates between the treatment groups and three of the
studies utilized regression methods that permitted controlling for covariates (Hopfer, 2012; Patel et al., 2012; Venkatesan, 2011).

increase uptake of the vaccine. Articles were excluded if they only included a pediatric or non-student population, focused on parent/caregiver interventions, were survey studies that did not include an intervention, were not peer-reviewed, or were not directly related to HPV
vaccination. Two authors (MB and AC) screened titles and abstracts for
inclusion in the full-text review, with a third author (LW) resolving any
discrepancies. A total of 101 articles were identiﬁed for full-text review.
The data charting process was conducted via a Qualtrics data entry
form. The form was tested by the team, with all team members completing reviews of several articles to ensure the abstraction process was
uniform. Data items abstracted included study design and duration,
population (inclusion criteria, demographics, HPV vaccination status),
intervention and comparison treatment descriptions, treatment allocation, blinding, HPV vaccine outcomes and follow-up length, integrity of
and adherence to the intervention, management of missing participants,
other variables assessed (e.g., knowledge, attitudes about vaccines),
and funding source. The charting was conducted by three authors (AC,
EG, and MC) and a fourth author (MB) resolved any discrepancies.
Additionally, references in all articles for which a full-text review was
completed were scanned for potential identiﬁcation of any references
that may not have been identiﬁed in the original search. No additional
references were identiﬁed. After full-text review, 92 articles were excluded. Studies were excluded after full text review if they did not report on an intervention, did not focus on college students, were dissertations whose peer-reviewed publications were included in the
review, did not have full text available in English, were a repeat publication of the same study data, or only reported on intention to get the
HPV vaccination rather than reporting actual vaccine uptake. HPV
vaccine uptake was the main outcome abstracted. See Fig. 1 for the
PRISMA ﬂow diagram which describes the article selection process. An
inductive content analysis of the abstracted data was conducted to
identify themes by two authors separately (MB and EG) and then reviewed and conﬁrmed by all authors. Data were organized and reported
by the identiﬁed themes.

3.2. Interventions
None of the studies, brieﬂy described in Table 1, used the same
intervention. Interventions ranged from tailored messages on websites
to gain and loss-framed video messages, stigmatizing and fear-oriented
messages to enhanced reminder systems. Most (7 of 9) used some sort of
educational intervention (Bennett et al., 2015; Gerend and Shepherd,
2012; Hopfer, 2012; Juraskova et al., 2011; Patel et al., 2012; Perez
et al., 2016; Richman et al., 2016). The studies that achieved at least a
20% uptake of at least the ﬁrst dose utilized interventions that would be
relatively easy to implement as they are relatively inexpensive and easy
to disseminate widely. Hopfer demonstrated a 21.8% vaccination uptake rate of at least one dose in the group that watched a peer and
medical expert-led video about the vaccination (Hopfer and Clippard,
2011). Juraskova et al. achieved a 44% uptake rate of one dose with an
information leaﬂet that describe the vaccines protection from cervical
cancer and genital warts and Richman et al. achieved completion of two
doses in 53% and three doses in 34% of the intervention group which
received monthly health education and reminder prompts (Juraskova
et al., 2011; Richman et al., 2016).
3.3. Combined peer and provider impact
While only one of these interventions had a signiﬁcant impact on
increasing uptake compared to the comparison condition in each study,
there was a common intervention component associated with a nonsigniﬁcant but positive impact on vaccine uptake in three of the studies.
Hopfer found the highest uptake in the combined peer and medical
expert-led vaccination video condition (Hopfer, 2012). Long et al. increased the number of vaccines administered year-to-year with the inclusion of language-speciﬁc education to Chinese students provide by
peer educators, and Venkatesan reported that participants who got the
ﬁrst vaccine dose were more likely to have consulted family and friends
in addition to their healthcare provider compared to participants who
did not get the vaccine (Long et al., 2017; Venkatesan, 2011). A combination of both peer and provider support may be critical to increasing
college students' uptake of the vaccine.

3. Results
The nine articles selected for review are summarized in Table 1. All
of the studies were randomized controlled trials except for one. Most of
the studies (7 of 9) only included female participants. All of the studies
were conducted in the United States, except for one which was conducted in Australia. Six studies tested interventions in controlled lab
settings, two did so in health care clinics, and one in a health fair setting. The risk of bias at the study level was assessed utilizing the Cochrane Collaboration's tool for assessing risk of bias and potential biases
are identiﬁed in Table 1 (Higgins and Green, 2011).

3.4. Knowledge and perception of HPV and HPV vaccine
3.1. HPV vaccine uptake rates
While the primary outcome of interest was HPV vaccine uptake,
most of the studies (8 of 9) included in this review also included assessment of knowledge and perceptions related to HPV and the HPV
vaccine. Few of the studies (3 of 9) included the descriptive statistics for
knowledge measures by group and pre/post intervention and there was
no common method of assessing knowledge. Bennett et al. (2015) reported an increase in the proportion of participants with high levels of
HPV and HPV vaccine knowledge after the intervention, increasing
from 32% to 50% of the participants. However, they noted that in the
multivariate model, knowledge was not associated with vaccine uptake
(Bennett et al., 2015). Richman et al. (2016) found a greater increase in
knowledge of HPV and the HPV vaccine in the treatment group compared to the control group, but they did not include knowledge in the
predictor model so the impact on vaccine uptake is unclear (Richman
et al., 2016). Others reported no diﬀerence in HPV-related knowledge
between the intervention and control groups and did not include
knowledge as a predictor of vaccine uptake (Juraskova et al., 2011;
Perez et al., 2016). Assessment of perceptions related to HPV and the

There was wide variation in the length of follow-up (4 weeks to
10 months) and the rate of HPV vaccine initiation and completion
(5–53%) across the studies. Only one randomized trial demonstrated
increased uptake of at least one dose in the intervention compared to
the control condition (Hopfer, 2012). However, studies varied widely in
actual rates of vaccine uptake and often utilized two interventions
without a control condition for comparison. For example, Bennet et al.
had a 7.83% uptake of one dose in the intervention group and 8.73% in
the control group whereas Juraskova et al., which examined two interventions head-to-head, achieved 32% uptake of at least one dose in
one group and 44% in the other group (Bennett et al., 2015; Juraskova
et al., 2011). Diﬀerences in uptake rate may be related to the length of
time participants were followed and whether they reported uptake
based on at least one dose or completion of the vaccine series. One
study assessed vaccine uptake at four weeks post-intervention (Perez
et al., 2016) and four assessed this at two to three months post-intervention (Bennett et al., 2015; Hopfer, 2012; Juraskova et al., 2011;
3
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Patel et al. (2012)

Long et al. (2017)

Juraskova et al.
(2011)

Hopfer (2012)

Gerend and
Shepherd
(2012)

Randomized controlled trial

Bennett et al.
(2015)

Randomized controlled trial

Potential selection, performance,
detection, attrition, and reporting biases

Single arm pre-post study

Potential selection, performance and
detection biases due to lack of clear
randomization method, blinding of
participants, personnel, and outcome
assessment

Randomized controlled trial

Potential selection, performance and
detection biases due to lack of clear
randomization method, blinding of
participants, personnel, and outcome
assessment

Randomized controlled trial

Potential selection, performance and
detection biases due to lack of clear
randomization method, blinding of
participants, personnel, and outcome
assessment

Potential performance and detection
biases due to lack of blinding of
participants, personnel, and outcome
assessment
Randomized controlled trial

Randomized via automated algorithm
and stratiﬁed by age (< 21 or ≥21)

Research design, randomization method,
and bias assessment

Author (year)

Table 1
Summary of articles selected for systematic review.

Female U.S. university undergraduate and
graduate students aged 18–26 who

Chinese students at a U.S. university

Non- HPV vaccinated female Australian
university undergraduate students under
the age of 27 (n = 159)

HPV vaccine uptake of at least one dose
6 months after the intervention as

HPV/HPV vaccine knowledge,
perceived severity, susceptibility,
barriers and beneﬁts, along with cues to
action and vaccine preference and
intention were also assessed
Overall HPV vaccination rate at the
university (no information about
number of doses per patient)

HPV vaccine uptake of at least one dose
2 months after the intervention

HPV knowledge was also assessed

HPV vaccine uptake of at least one dose
2 months after the intervention

Perceived susceptibility, severity, and
barriers, attitudes, subjective norms,
self-eﬃcacy, and vaccination intention
were also assessed

(continued on next page)

Overall, 14 (5.5%) participants received
at least 1 HPV vaccine dose within

HPV vaccinations increased by 41%
compared with the same period the year
before (331 vs 235 HPV vaccine doses)
and 83.7% (277) of the doses were
administered to Chinese students

No signiﬁcant diﬀerence in HPV vaccine
uptake across the two experimental
conditions
(32% in the leaﬂet about cervical cancer
only group, 44% in the leaﬂet about
cervical cancer plus genital warts group)

The peer and medical expert-led
vaccination video was associated with
increases in receiving at least on HPV
vaccine dose (21.8%) compared to peer
alone (17.8%), provider alone (6.0%),
and control (11.8%).

No signiﬁcant diﬀerence in HPV vaccine
uptake across the three experimental
conditions (5% gain frame, 6% loss
frame, 7% control)

HPV vaccine uptake of at least one dose
10 months after the intervention

Participants were randomized to be
exposed to one of three HPV vaccine
education videos a) a gain-framed video
message focused on vaccination beneﬁts
(n = 250); b) a loss-framed video message
focused on costs of not getting vaccinated
(n = 243); or c) a control video with no
framed information (n = 246);
intervention was a one-time viewing
Female students were presented with
videos of HPV vaccine decision narratives
that included HPV susceptibility, vaccine
self-eﬃcacy, and vaccine safety narratives,
and narratives prompting college women to
vaccinate themselves regardless of their
data status. The video narratives were
either delivered by peers (101 viewed these
videos), by medical experts (50 viewed
these), or presented by a combination of
both peers and medical experts (101
viewed these), or control videos of
information without narratives, the campus
website about HPV and the vaccine or no
message (these control conditions, viewed
by a total of 152 participants, were
collapsed for analysis as one control group)
Participants were randomized to be
exposed to an information leaﬂet either
about the HPV vaccine protecting against
cervical cancer or a leaﬂet about protecting
against cervical cancer plus genital warts
(which tested whether a potentially
“sexualized” or stigmatized message would
impact uptake)
Pharmacy school operation immunization
utilized a peer to peer model with two
Chinese pharmacy students speaking in the
Chinese language to Chinese students to
encourage HPV vaccination. An email was
also sent to a UW Chinese freshmen student
email list and prepared ﬂyers in simpliﬁed
Chinese at ﬂu shot clinics on campus.
Participants were randomized to receive
HPV-speciﬁc patient education plus

Non-HPV vaccinated female U.S.
university students aged 18–26 and not
pregnant
(n = 739)

Non-HPV vaccinated female U.S.
university undergraduate and graduate
students aged 18–26 who had not
previously been seen at the university's
campus health center (n = 404)

No signiﬁcant diﬀerence in HPV vaccine
uptake (7.83% intervention vs. 8.73%
control completed ﬁrst dose; 3.31%
intervention vs. 3.61% control
completed two doses; 0.60%
intervention vs. 1.2% control completed
three doses)

HPV vaccine uptake (including how
many doses) 3 months after
randomization

Participants were randomized to receive an
individually tailored online education
intervention (‘Me First’) or the control
website showing the CDC vaccine
information statement; intervention was
one time viewing

Non-HPV vaccinated female U.S.
university undergraduate and graduate
students aged 18–26 who (n = 661)
(67.3% undergraduate students, 27.5%
graduate students, 5/1% professional
students)
HPV/HPV vaccine knowledge, risk
perception, and intention were also
assessed

Intervention eﬀects

Outcome & explanatory variables

Intervention/duration

Sample and sample size

M. Barnard, et al.
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Venkatesan (2011)

Richman et al.
(2016)

Perez et al. (2016)

Author (year)

Table 1 (continued)

5

Potential performance and detection
biases due to lack of blinding of
participants, personnel, and outcome
assessment; reporting bias due to
incomplete outcome reporting

Assigned to condition via a coin ﬂip

Potential selection, performance and
detection biases due to lack of clear
randomization method, blinding of
participants, personnel, and outcome
assessment
Randomized controlled trial

Randomized controlled trial

Potential performance and detection
biases due to lack of blinding of
participants, personnel, and outcome
assessment; reporting bias due to
incomplete outcome reporting

Randomized via scheduling; participants
remained blinded to study condition

Potential performance and detection
biases due to lack of blinding of
participants, personnel, and outcome
assessment; reporting bias due to
incomplete outcome reporting
Randomized controlled trial

Non-HPV vaccinated female U.S.
university undergraduate students mean
age 19.03 (2.49) years recruited from an
undergraduate Psychology pool (n = 72)

Male and female U.S. university
undergraduate and graduate students aged
18–26 who were voluntarily initiating the
ﬁrst HPV vaccine dose from the campus
student health center (n = 264)

Non-HPV vaccinated female U.S.
university undergraduate students aged
18–26 (n = 70)

Participants were randomly assigned to
listen to either a high or low threat fear
communication about HPV. High threat
messages emphasized the susceptibility to
HPV among college-aged women using
personalized language whereas the low
threat message describe susceptibility to
HPV among women in general and
included the low prevalence rates for
cervical cancer.

Participants participated in either an active
intervention (AI) or an attention control
(AC) group. AI received HPV education
content speciﬁc to knowledge gaps
identiﬁed among young adult women,
motivational and skills-building content,
information on where to access and how to
pay for the vaccine, reminder tools and
guidance to communicate vaccine interest
with parents and providers. AC watch
video clips on women's health topics.
Participants were randomized to receive an
electronic message per month for 7 months
(health education and reminder messages)
or standard care which provided a paper
card with date of next appointment

6 months of study enrollment. Data is not
provided separately for each treatment
condition, although the authors report
no diﬀerence between the treatment
groups.

documented in medical record

reminder letter or standard care in which
HPV vaccination is brieﬂy mentioned to all
patients

attended the university's health service
gynecology clinic for routine exam, and
had not previously received the HPV
vaccination (n = 256)

Randomized via a computer
randomization program with assignment
revealed after consent

Attitudes, intentions, information
seeking behavior and knowledge
retention about HPV/HPV vaccine were
also assessed

HPV vaccine uptake of at least one dose
6 weeks after the intervention

HPV and HPV vaccine knowledge were
also assessed

Participants who got the vaccine
reported that they were more likely to
have consulted friends and family in
addition to their doctor.

No signiﬁcance in HPV completion
across the two experimental conditions.
HPV vaccine dose 2 was completed by
53% of intervention group and 52% of
control group. HPV vaccine dose 3 was
completed by 34% of intervention group
and 32% of control group.
3 participants (6.25%) obtained the
vaccine (data not presented by
intervention group).
HPV vaccine uptake and completion
7 months after the intervention

Motivation to get vaccinated and
perceived eﬃcacy and diﬃculty were
also assessed

No signiﬁcant diﬀerence in HPV vaccine
uptake across the two experimental
conditions.
Data is not provided in aggregate nor
separately for the treatment groups,
although the authors report no
diﬀerence between the treatment
groups.

HPV vaccine uptake of at least one dose
4 weeks after the intervention

HPV/HPV vaccine knowledge, personal
beliefs, and intention to vaccinate were
also assessed

Intervention eﬀects

Outcome & explanatory variables

Intervention/duration

Sample and sample size

Research design, randomization method,
and bias assessment

M. Barnard, et al.
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vaccination. Further review of studies investigating vaccination intention as the primary outcome may be warranted to provide insight into
promising interventions that could be tested for impact on actual vaccination uptake. An additional limitation is the small number of studies
that included male participants. Only one study explicitly included
male participants (Richman et al., 2016) and another was a general
health education approach at a college of pharmacy operation immunization program which likely exposed both male and female students but did not report any data by sex (Long et al., 2017). As a result,
no conclusion can be made about whether these interventions would
potentially have any impact on male HPV vaccination uptake. This is
unfortunate as boys are less likely to be vaccinated as adolescents
compared to girls (Walker, 2017). Further, several of the studies had a
relatively short follow-up period. It is possible that participants went on
to eventually receive the vaccine after the follow-up assessment, which
may result in an underestimation of the impact of the interventions.
However, there is no clear reason to expect that there would have been
diﬀerences across the treatment conditions in delayed uptake.

HPV vaccine (e.g., perceived susceptibility, perceived risks and beneﬁts, subjective norms, and self-eﬃcacy) were guided by theories, including the Health Belief Model, the Theory of Planned Behavior,
Culture-Centric Narrative Theory, and Exempliﬁcation Theory. Variables from these theories were found to be associated with vaccine
uptake. For example, Gerend and Shepherd (2012) found that perceived
susceptibility, perceived barriers, intentions, subjective norms and selfeﬃcacy predicted vaccine uptake and Hopfer (2012) found that vaccine
intent mediated the impact of the intervention on vaccine uptake
(Gerend and Shepherd, 2012; Hopfer, 2012; Juraskova et al., 2012).
4. Discussion
The suboptimal HPV vaccination uptake in the U.S. population
warrants attention to reach the Healthy People 2020 goal of 80% of all
adolescents completing the HPV vaccine series (Immunization and
Infectious Diseases | Healthy People 2020, 2019). Eﬀective interventions are needed to improve catch-up vaccination rates. College health
centers are optimally positioned to facilitate catch-up vaccination as
college students are making their own health decisions, over 80% have
health insurance that would cover the cost of the vaccination, and have
easy access on campuses to complete the multi-shot vaccination (United
States Government Accountability Oﬃce, 2008). Determining what
kind of health education program will be eﬀective at increasing vaccination rates is essential. To date there has been nearly no replication
of speciﬁc interventions to increase HPV uptake in the young adult
population making it diﬃcult to identify interventions to recommend
for adoption. Current literature indicates that provider recommendations are one of the main predictors of HPV vaccine uptake in adolescents (Dempsey et al., 2019; Holloway, 2019). It is interesting to note
that the only intervention in this review that signiﬁcantly increased
HPV vaccine uptake was an educational intervention that utilized a
joint peer and medical provider message, which was found to be more
eﬀective than a message from a peer or provider alone (Hopfer, 2012).
The interventions that achieved the highest vaccination rates appear to
be relatively easy to implement, such as videos, leaﬂets, and monthly
reminders (Hopfer, 2012; Juraskova et al., 2011; Richman et al., 2016).
Replication of these interventions to examine eﬀectiveness in other
samples is needed. Further, there is a clear gender gap in the literature
as few studies have examined the impact of intervention vaccine uptake
by male students.
Importantly, all but one of the studies had a non-signiﬁcant treatment eﬀect. Diﬀerences in the sample characteristics, the control
groups' exposures, and other health care access and educational variables are potential drivers of the variation in ﬁndings related to vaccine
uptake. The lack of signiﬁcant diﬀerences between the intervention and
control conditions may indicate that simply participating in a study
related to HPV vaccination impacts uptake and thus the control conditions may have had higher uptake than would naturally have occurred. Manipulating messages to increase the perceived threat, tailoring educational messages, and reminder letters were utilized in
studies that found < 10% of participants went on to receive the HPV
vaccine (Bennett et al., 2015; Patel et al., 2012; Venkatesan, 2011).
While Juraskova et al. (2011) did not ﬁnd a signiﬁcant diﬀerence between two interventions, HPV vaccine uptake rates were relatively high
in both the group exposed to a leaﬂet focused on the protective eﬀect of
the vaccine (32% uptake) and the group exposed to a leaﬂet with a
more stigmatizing message (42% uptake) (Juraskova et al., 2012).
There is clearly a need for further investigation of speciﬁc intervention
components to develop optimal intervention strategies.
There are several limitations to the current literature and review.
There are only a small number of studies that examine HPV vaccine
uptake as an outcome variable following an intervention among college
students. While many health behavior theories indicate that intention is
a precursor to behavior, there remains a need for studies that demonstrate actual eﬃcacy at completion of the behavior, in this case HPV

5. Conclusions
While there are many studies demonstrating improvement in vaccination intention, very few interventions targeting college students
have demonstrated eﬀectiveness at increasing actual HPV vaccine uptake. Based on nine studies that reported vaccine uptake rate as an
outcome, uptake rates for at least one dose of the vaccine varied from
5% to 53%. Program planners should focus on interventions that have
demonstrated the ability to improve vaccination rates. This review ﬁnds
that interventions that engage both peers and medical professionals
may be the most eﬀective way to increase uptake.
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